Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea

Inclusion Criteria: * 18-60 years old * Erythematotelangiectatic rosacea subtype * Willingness to participate in the research and providing informed consent Exclusion Criteria: * Patients under 18 years of age, over 60 years of age * A rosacea subtype other than ETR * History of using topical or systemic medications within the past two weeks due to rosacea or other dermatoses * Known history of autoimmune disease * History of neuromuscular disease * History of facial botulinum toxin injection within the last six months * Reporting allergy to the active ingredient * Pregnant or breastfeeding patients * Patients who do not accept treatment and follow-up